Patents by Inventor Daniel Resnicow

Daniel Resnicow has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Aptamers to ?-NGF and their use in treating ?-NGF mediated diseases and disorders
    Patent number: 8598140
    Abstract: The present disclosure relates generally to the field of nucleic acids and, more particularly, to aptamers capable of binding to ?-NGF; pharmaceutical compositions comprising such ?-NGF aptamers; and methods of making and using the same.
    Type: Grant
    Filed: April 12, 2011
    Date of Patent: December 3, 2013
    Assignees: SomaLogic, Inc., OTSUKA Pharmaceutical Co., Ltd.
    Inventors: Daniel J. Schneider, Akihiko Hisaminato, Sheela Waugh, Daniel Resnicow, Akira Nagabukuro, Toshihide Ono
  • Aptamers to Beta-NGF and Their Use in Treating Beta-NGF Mediated Diseases and Disorders
    Publication number: 20130012693
    Abstract: The present disclosure relates generally to the field of nucleic acids and, more particularly, to aptamers capable of binding to ?-NGF; pharmaceutical compositions comprising such ?-NGF aptamers; and methods of making and using the same.
    Type: Application
    Filed: April 12, 2011
    Publication date: January 10, 2013
    Applicants: OTSUKA PHARMACEUTICAL CO., LTD., SOMALOGIC, INC.
    Inventors: Daniel J. Schneider, Akihiko Hisaminato, Sheela Waugh, Daniel Resnicow, Akira Nagabukuro, Toshihide Ono